Mundipharma and Orexo to launch opioid dependence treatment Zubsolv outside US

Mundipharma has signed an agreement with Swedish-based pharmaceutical company Orexo to grant exclusive global (ex-US) rights to Mundipharma’s network of independent associated companies for Zubsolv (buprenorphine and naloxone sublingual tablet), for … (Source: Pharmaceutical Technology)